Esteves Lima Rafael Paschoal, Viana Karolina Skarlet Silva, Silva Junior Pierre Geraldo Braz da, Cota Luís Otávio Miranda, Costa Fernando Oliveira
Universidade Federal de Minas Gerais, Faculdade de Odontologia, Departamento de Clínica, Patologia e Cirurgias Odontológicas, Belo Horizonte, MG, Brasil.
J Appl Oral Sci. 2025 Jul 14;33:e20250121. doi: 10.1590/1678-7757-2025-0121. eCollection 2025.
The infectious and inflammatory process of the periodontal tissues can contribute to hyperglycemia in patients with diabetes. The objective of this study was to evaluate the effect of non-surgical periodontal therapy on glycemic control in individuals with type 2 diabetes mellitus.
In this clinical trial with two months of follow-up, 31 participants were included, with 15 having adequate glycemic control and 16 inadequate glycemic control. The participants underwent non-surgical periodontal therapy. Biological, social, and behavioral variables were collected. Periodontal clinical examination was performed at baseline and two months after the intervention. Laboratory tests to assess serum levels of glycated hemoglobin, fasting glucose, and C-reactive protein were requested for all participants at baseline and two months after periodontal treatment.
The difference in glycated hemoglobin levels between baseline and two months after non-surgical periodontal therapy was statistically significant in the total sample (p=0.045) and in the group of individuals with adequate glycemic control (p=0.016). No significant difference was observed in glycated hemoglobin levels in the group of individuals with inadequate glycemic control. No significant variation was observed in fasting glucose and C-reactive protein levels after treatment in the studied sample. A reduction in probing depth, gingival inflammation, and gain in clinical attachment was observed in the total sample and in both groups according to glycemic control.
Periodontal intervention may contribute to improved glycemic control in individuals with type 2 diabetes mellitus and periodontitis (Brazilian Clinical Trials Registry RBR-9fvwk4m).
牙周组织的感染和炎症过程可能导致糖尿病患者血糖升高。本研究的目的是评估非手术牙周治疗对2型糖尿病患者血糖控制的影响。
在这项为期两个月随访的临床试验中,纳入了31名参与者,其中15名血糖控制良好,16名血糖控制不佳。参与者接受了非手术牙周治疗。收集了生物学、社会和行为变量。在基线和干预后两个月进行牙周临床检查。要求所有参与者在基线和牙周治疗后两个月进行实验室检查,以评估糖化血红蛋白、空腹血糖和C反应蛋白的血清水平。
在整个样本中(p=0.045)以及血糖控制良好的个体组中(p=0.016),非手术牙周治疗后两个月与基线之间糖化血红蛋白水平的差异具有统计学意义。在血糖控制不佳的个体组中,糖化血红蛋白水平未观察到显著差异。在研究样本中,治疗后空腹血糖和C反应蛋白水平未观察到显著变化。根据血糖控制情况,在整个样本以及两组中均观察到探诊深度降低、牙龈炎症减轻和临床附着增加。
牙周干预可能有助于改善2型糖尿病合并牙周炎患者的血糖控制(巴西临床试验注册中心RBR-9fvwk4m)。